Preliminary data from Israel this week regarding Pfizer’s vaccine for the coronavirus is raising questions about how vaccines work over time against variants like delta. To break this down, host Marco Werman speaks with Dr. Anna Durbin, a professor of international health at Johns Hopkins Bloomberg School of Public Health. Durban explains why she still doesn’t find such results worrying.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?